Chittorgarh.com Logo
Loading...

Par Drugs IPO Details

IPO Open May 3, 2019
IPO Close May 8, 2019
IPO Price ₹51
Face Value ₹10
IPO Size ₹8.53 Cr
Listing At NSE SME
Lot Size 2000
Open an Instant Account with Zerodha
  1. Parenteral Drugs IPO

    Sep 27, 2022 4:26:00 AM

    The IPO page of Parenteral Drugs (India) Ltd. captures the details on its Issue Open Date, Issue Close Date, Listing Date, Face Value, Price band, Issue Size, Issue Type, and Listing Date's Open Price ...

    Publish by : Indiatimes
  2. Prime Medicines Files for IPO, Revealing 18-Program Pipeline and First Patent

    Sep 27, 2022 12:07:00 PM

    estimated that Prime’s IPO “could raise up to $200 million,” making it among the year’s three largest initial public offerings for a biotech company, following vision care drug/device ...

    Publish by : GEN
  3. Welcure Drugs & IPO

    Sep 28, 2022 6:05:00 PM

    The IPO page of Welcure Drugs & Pharmaceuticals Ltd. captures the details on its Issue Open Date, Issue Close Date, Listing Date, Face Value, Price band, Issue Size, Issue Type, and Listing Date's ...

    Publish by : Indiatimes
  4. What Is An IPO?

    Sep 22, 2022 8:47:00 PM

    Commissions do not affect our editors' opinions or evaluations. An IPO is an initial public offering. In an IPO, a privately owned company lists its shares on a stock exchange, making them ...

    Publish by : Forbes
  5. Fundrise IPO: Information for Investors

    Sep 22, 2022 5:19:00 PM

    Moreover, Fundrise came up with an innovative way to raise capital through an internet public offering. Through the IPO, existing investors can contribute funds and get equity stakes in the company ...

    Publish by : Investment U
  6. Anticoagulant drug developer Cardrenal Therapeutics files for $10M IPO

    Sep 23, 2022 9:52:00 PM

    Anticoagulant drug developer Cardrenal Therapeutics (CVKD ... Phase 3 clinical trial for the product in 2023. For more IPO news, check out SA's IPO News page.

    Publish by : Seeking Alpha
  7. IPO Plus - IPO Main Page

    Sep 29, 2022 3:30:00 AM

    4.If the company is listed by way of introduction, or transferred to the Main Board from GEM, opening price on debut will be deemed as the Listing Price. 5.% Chg. on debut: [(Closing price on ...

    Publish by : ???????
  8. Borders drugs firm plans IPO after £4.45m acquisition

    Sep 24, 2022 12:08:00 AM

    A Scottish biotech company is aiming for an IPO after raising £4.45 million to acquire a business in the south of England. Ryboquin has bought Sussex-based Nanogenic Solutions to form a new product ...

    Publish by : dailybusinessgroup
  9. How the IPO market went from boom to bust

    Sep 24, 2022 2:24:00 PM

    "Investors are really risk averse at this moment, and that's what's really impacting the lack of activity that we're seeing," said Rachel Gerring, IPO leader at EY Americas, in an interview with CNBC.

    Publish by : CNBC
  10. Chobani withdraws IPO plans after yogurt maker filed in November to go public

    Sep 3, 2022 2:30:00 AM

    Chobani joins payroll vendor Justworks, grocer Fresh Market and file-sharing company WeTransfer in canceling its IPO this year. In an emailed statement, Chobani cited current market conditions for ...

    Publish by : CNBC
  11. Demand for Porsche IPO races past deal size

    Sep 20, 2022 3:52:00 PM

    STORY: Demand for the hotly anticipated Porsche IPO has raced past the number of shares on offer. A source close to the deal says the offering already looks hugely oversubscribed, with the books ...

    Publish by : Yahoo News Canada
  12. Porsche’s blockbuster IPO will copy Ferrari’s and sets it up to compete with Tesla

    Sep 23, 2022 4:34:00 PM

    Its profit margins are lavish. The Porsche IPO should happen in the next couple of weeks, even though the war in Ukraine and the energy crisis it triggered have put investors everywhere on edge.

    Publish by : The Globe and Mail

Par Drugs IPO Alerts

1. Par Drugs IPO Allotment Status  Tuesday, May 14, 2019 12:44:15 AM

The allotment status of Par Drugs and Chemicals Limited IPO is now available online. The public issue of Par Drugs IPO was open on May 3, 2019 and closed for subscription on May 8, 2019. The equity shares of the company to be list at NSE SME.

2. Par Drugs IPO Listing Date & Info  Monday, May 13, 2019 11:18:15 PM

The IPO Shares of Par Drugs and Chemicals Limited IPO are proposed to list on Thursday, May 16, 2019 at NSE SME. The public issue of Par Drugs IPO was opened on May 3, 2019 and closed for subscription on May 8, 2019. Par Drugs IPO Listing Date and Information:

  • Listing Date: Thursday, May 16, 2019
  • BSE Script Code:
  • NSE Symbol: PAR
  • Listing In:
  • ISIN:
  • Issue Price: 51
  • Face Value: Rs 10 Per Equity Share

3. par drugs ipo Opens on May 3, 2019  Friday, April 26, 2019 10:48:34 AM

Par Drugs and Chemicals Limited is entering in the capital market with an IPO of 1,700,000 Equity Shares of Rs 10 aggregating up to Rs 8.53 Crore. The price for the issue has been set at Rs 51 Per Equity Share.

Incorporated in 1999, Gujarat based Par Drugs and Chemicals Limited is engaged in the business of manufacturing and developing active pharma ingredients (API) for the Indian and international markets. APIs are used as the main ingredient in making tablets, capsules, and other finished dosages. The company also produces various antacid molecules which are in great demand in the market.

The issue opens on May 3, 2019 and closes for subscription on May 8, 2019. The equity shares of the company to be list at NSE SME.

4. par drugs ipo Closes on May 8, 2019  Friday, April 26, 2019 10:48:34 AM

The issue of Par Drugs and Chemicals Limited opens on May 3, 2019 and closes for subscription on May 8, 2019. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 51 Per Equity Share.

Par Drugs IPO News & Events FAQs

The Par Drugs IPO is proposed to open on May 3, 2019. The IPO application ends on May 8, 2019.

Retail investors can apply in the retail or non-institutional investor category from May 3, 2019 to May 8, 2019. The Par Drugs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Par Drugs IPO will open for subscription on May 3, 2019. The public issue will close on May 8, 2019.